Central vagal activation by alpha₂‐adrenergic stimulation is impaired in spontaneously hypertensive rats

Abstract

Medetomidine-induced central vagal activation was impaired in SHR, whereas peripheral vagal control of ACh release was preserved. In addition to abnormal sympathetic control, vagal control by the central nervous system may be impaired in SHR.